BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
05.09.24
/
50%
€75.46
Target price
05.09.25
€109.96
Performance (%)
-34.85%
End price
06.09.25
€49.16
Summary
This prediction ended on 06.09.25 with a price of €49.16. The BUY prediction by Piper_Sandler for BioMarin Pharmaceutical Inc. performed very badly with a performance of -34.85%. Piper_Sandler has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.635% | 5.635% | -18.419% |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Piper Sandler from $107.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.09
06.02.26
06.02.26
€71.25
06.02.27
06.02.27
8.45%
23.02.26
23.02.26
Stopped prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€120.57
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.88
27.08.24
27.08.24
€95.81
27.08.25
27.08.25
-38.16%
28.08.25
28.08.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.34
23.02.24
23.02.24
€98.83
23.02.25
23.02.25
-22.62%
24.02.25
24.02.25